About FDA

Patient-Focused Drug Development Program Staff

The Patient-Focused Drug Development Program Staff leads initiatives and provides strategic, regulatory, program, and policy assistance within the Center for Drug Evaluation and Research (CDER) to facilitate the incorporation of patient input into decision-making.

What We Do

  • Design, develop, and implement programs to facilitate the incorporation of patient input into decision-making.
  • Advise and support CDER and collaborate with other FDA Centers to advance the use and role of patient experience data in regulatory decision-making.  
  • Lead and manage Center activities related to patient-focused drug development provisions under the 21st Century Cures Act and the Food and Drug Administration Reauthorization Act (FDARA), which reauthorizes the Prescription Drug User Fee Act (PDUFA). This effort includes the development of a guidance series on the collection of patient experience data, and the use of such data and related information in drug development and decision-making. 

  • Develop and manage CDER’s External Resources or Information Related to Patients’ Experience pilot webpage.
  • Conduct outreach and engage with external stakeholders to advance the integration of patient input into drug development and decision-making.
  • Serve as CDER’s primary point of contact for patient-focused drug development activities.
  • Advance the science of patient input through workshops, conferences and publications.

Useful Links

Contact Us

Email: patientfocused@fda.hhs.gov

Page Last Updated: 11/07/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English